Literature DB >> 8631783

A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.

G E Cartier1, D Yoshikami, W R Gray, S Luo, B M Olivera, J M McIntosh.   

Abstract

We have isolated a 16-amino acid peptide from the venom of the marine snail Conus magus which potently blocks nicotinic acetylcholine receptors (nAChRs) composed of alpha3beta2 subunits. This peptide, named alpha-conotoxin MII, was identified by electrophysiologically screening venom fractions against cloned nicotinic receptors expressed in Xenopus oocytes. The peptide's structure, which has been confirmed by mass spectrometry and total chemical synthesis, differs significantly from those of all previously isolated alpha-conotoxins. Disulfide bridging, however, is conserved. The toxin blocks the response to acetylcholine in oocytes expressing alpha3beta2 nAChRs with an IC50 of 0.5 nM and is 2-4 orders of magnitude less potent on other nAChR subunit combinations. We have recently reported the isolation and characterization of alpha-conotoxin ImI, which selectively targets homomeric alpha7 neuronal nAChRs. Yet other alpha-conotoxins selectively block the muscle subtype of nAChR. Thus, it is increasingly apparent that alpha-conotoxins represent a significant resource for ligands with which to probe structure-function relationships of various nAChR subtypes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631783     DOI: 10.1074/jbc.271.13.7522

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  167 in total

1.  Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus.

Authors:  A R McQuiston; D V Madison
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  A comparative study on selectivity of alpha-conotoxins GI and ImI using their synthetic analogues and derivatives.

Authors:  Igor E Kasheverov; Maxim N Zhmak; Innokenty V Maslennikov; Yuri N Utkin; Victor I Tsetlin
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

3.  Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

Authors:  Michele Zoli; Milena Moretti; Alessio Zanardi; J Michael McIntosh; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Reduction of neuromuscular activity is required for the rescue of motoneurons from naturally occurring cell death by nicotinic-blocking agents.

Authors:  R W Oppenheim; D Prevette; A D'Costa; S Wang; L J Houenou; J M McIntosh
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

5.  Mice lacking specific nicotinic acetylcholine receptor subunits exhibit dramatically altered spontaneous activity patterns and reveal a limited role for retinal waves in forming ON and OFF circuits in the inner retina.

Authors:  A Bansal; J H Singer; B J Hwang; W Xu; A Beaudet; M B Feller
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

6.  Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior.

Authors:  B N Cohen; E D W Mackey; S R Grady; S McKinney; N E Patzlaff; C R Wageman; J M McIntosh; M J Marks; H A Lester; R M Drenan
Journal:  Neuroscience       Date:  2011-11-04       Impact factor: 3.590

Review 7.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 8.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

9.  Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.

Authors:  Andrew M Smith; Marharyta Pivavarchyk; Thomas E Wooters; Zhenfa Zhang; Guangrong Zheng; J Michael McIntosh; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2010-03-25       Impact factor: 5.858

10.  BmTx3, a scorpion toxin with two putative functional faces separately active on A-type K+ and HERG currents.

Authors:  Isabelle Huys; Chen-Qi Xu; Cheng-Zhong Wang; Hélène Vacher; Marie-France Martin-Eauclaire; Cheng-Wu Chi; Jan Tytgat
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.